California Bill Would Stop Insurers From Blocking Rare Disease Care

I've spent recent months working alongside legislators, patient advocates, and researchers who've had enough. Assembly Bill 1887, authored by the chair of the Rare Disease Caucus, Assemblymember Rick Zbur, would eliminate prior authorization and step therapy requirements for FDA-approved rare disease treatments when a specialist has determined the treatment is medically necessary. It's a meaningful solution for patients with the fewest alternatives and the least time to spare, and it will undoubtedly save lives.